找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Essentials of Clinical Research; Stephen P. Glasser Textbook 2014Latest edition Springer International Publishing Switzerland 2014 clinica

[復(fù)制鏈接]
查看: 40800|回復(fù): 62
樓主
發(fā)表于 2025-3-21 16:45:42 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Essentials of Clinical Research
編輯Stephen P. Glasser
視頻videohttp://file.papertrans.cn/316/315624/315624.mp4
概述Thoroughly updated and expanded for the Second Edition.Includes new material on the net reclassification index; the p value and Bayesian approaches and more.Offers new discussion of clinical practice
圖書(shū)封面Titlebook: Essentials of Clinical Research;  Stephen P. Glasser Textbook 2014Latest edition Springer International Publishing Switzerland 2014 clinica
描述.In its extensively revised and updated Second Edition, this book provides a solid foundation for readers interested in clinical research. Discussion encompasses genetic, pharmacoepidemiologic and implementation research..All chapters have been updated with new information and many new tables have been added to elucidate key points. The book now offers discussion on how to handle missing data when analyzing results, and coverage of Adaptive Designs and Effectiveness Designs and new sections on Comparative Effectiveness Research and Pragmatic Trials. Chapter 6 includes new material on Phase 0 Trials, expanded coverage of Futility Trials, a discussion of Medical Device approval, Off Label Drug use and the role of the FDA in regulating advertising. Additional new information includes the role of pill color and shape in association with the placebo effect and an examination of issues surrounding minority recruitment. The final chapter offers a new section on manuscript preparationalong with a discussion of various guidelines being adopted by journals: CONSORT, STROBE, PRISMA, MOOSE and others; and coverage of Conflicts of Interest, Authorship, Coercive Citation, and Disclosures in Indu
出版日期Textbook 2014Latest edition
關(guān)鍵詞clinical research; clinical trials; metaanalysis; new drug development; pharmacoepidemiology; placebo and
版次2
doihttps://doi.org/10.1007/978-3-319-05470-4
isbn_softcover978-3-319-37683-7
isbn_ebook978-3-319-05470-4
copyrightSpringer International Publishing Switzerland 2014
The information of publication is updating

書(shū)目名稱Essentials of Clinical Research影響因子(影響力)




書(shū)目名稱Essentials of Clinical Research影響因子(影響力)學(xué)科排名




書(shū)目名稱Essentials of Clinical Research網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Essentials of Clinical Research網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Essentials of Clinical Research被引頻次




書(shū)目名稱Essentials of Clinical Research被引頻次學(xué)科排名




書(shū)目名稱Essentials of Clinical Research年度引用




書(shū)目名稱Essentials of Clinical Research年度引用學(xué)科排名




書(shū)目名稱Essentials of Clinical Research讀者反饋




書(shū)目名稱Essentials of Clinical Research讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:38:24 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:02:53 | 只看該作者
地板
發(fā)表于 2025-3-22 07:57:00 | 只看該作者
nalong with a discussion of various guidelines being adopted by journals: CONSORT, STROBE, PRISMA, MOOSE and others; and coverage of Conflicts of Interest, Authorship, Coercive Citation, and Disclosures in Indu978-3-319-37683-7978-3-319-05470-4
5#
發(fā)表于 2025-3-22 10:08:02 | 只看該作者
978-3-319-37683-7Springer International Publishing Switzerland 2014
6#
發(fā)表于 2025-3-22 15:41:15 | 只看該作者
https://doi.org/10.1007/978-3-319-05470-4clinical research; clinical trials; metaanalysis; new drug development; pharmacoepidemiology; placebo and
7#
發(fā)表于 2025-3-22 20:02:47 | 只看該作者
8#
發(fā)表于 2025-3-23 00:52:40 | 只看該作者
Controlling in Unternehmensnetzwerkenies to randomized control trials (RCTs). This chapter addresses the definition of clinical research, the major aspects of clinical trials e.g. ethics, randomization, masking, recruitment and retention of subjects enrolled in a clinical trial, patients/subjects lost to follow-up during the trial etc.
9#
發(fā)表于 2025-3-23 04:27:29 | 只看該作者
10#
發(fā)表于 2025-3-23 07:02:09 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 14:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
麻江县| 乌拉特后旗| 耒阳市| 常德市| 铜梁县| 沂源县| 大田县| 仁化县| 西城区| 泰来县| 韶关市| 荣昌县| 盐津县| 都安| 日照市| 二连浩特市| 庐江县| 涪陵区| 南江县| 高要市| 耒阳市| 霞浦县| 福鼎市| 长治市| 石柱| 雷波县| 泰宁县| 泾源县| 易门县| 大余县| 泰来县| 丰都县| 襄垣县| 饶平县| 株洲县| 双鸭山市| 涞水县| 金溪县| 深州市| 新泰市| 井冈山市|